Facebook Linkedin Twitter
Inside Precision Medicine Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA

Pulmonary hypertension

Close-up of Internal organs dummy on white background. Human anatomy model. Heart Anatomy Internal.
News & Features

Merck’s First-in-Class Drug for Pulmonary Arterial Hypertension Approved by the FDA

Chris Anderson -
0
Diseased lung, conceptual illustration to illustrate pulmonary fibrosis
Molecular Dx

Biomarkers Found for Pulmonary Arterial Hypertension

Malorye Branca -
0
Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which are being targeted by Verve Therapeutics
News & Features

First Genome Editing of Blood Vessel Cell Walls

Malorye Branca -
0
Diseased lung, conceptual illustration to illustrate pulmonary fibrosis
Informatics

Cancer Drugs Could Be Used to Treat Pulmonary Hypertension

Helen Albert -
0
Owlstone Medical, Thermo Fisher Forge Breath Biopsy Technology Collaboration
Molecular Dx

Owlstone Medical, Thermo Fisher Forge Breath Biopsy Technology Collaboration

Chris Anderson -
0
Owlstone Medical to Collaborate on Breath-Based Pulmonary Hypertension Test
Molecular Dx

Owlstone Medical to Collaborate on Breath-Based Pulmonary Hypertension Test

Chris Anderson -
0
SQI Diagnostics will partner with University Health Network (UHN) to create and license rapid multiplexed protein assays and a point-of-care (POC) diagnostic device designed to help transplant surgeons assess the suitability of lungs and other organs for transplantation
Molecular Dx

SQI Diagnostics Partners with UHN on Diagnostic for Lung Transplantation

Inside Precision Medicine Staff Writer -
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine